425: Strive CRO Reposts Merger Update with Semler Scientific

Strive's Chief Risk Officer reposted a communication regarding the proposed business combination with Semler Scientific, highlighting the ongoing process and associated risks.

Summary

• Strive, Inc. (Strive) and Semler Scientific, Inc. (Semler Scientific) are engaged in a proposed business combination.
• The communication, reposted by Jeff Walton, Strive's Chief Risk Officer, on November 10, 2025, is a Form 425 filing related to this transaction.
• The filing emphasizes forward-looking statements concerning the merger's outlook, strategic and financial benefits, timing, and integration success.
• It includes a comprehensive cautionary statement detailing various risks that could cause actual results to differ materially from anticipated outcomes.

Sentiment

Score: 5

Explanation: The filing is a procedural communication related to a proposed business combination, primarily focused on forward-looking statements and comprehensive risk disclosures. It does not present new financial results or operational updates that would significantly alter sentiment, maintaining a neutral stance on current performance.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.
• The combined company anticipates positive impacts on its future financial performance.

Risks

• The merger agreement between Strive and Semler Scientific could be terminated due to various events, changes, or circumstances.
• The proposed transaction may not close as expected or at all if conditions to closing are not met or satisfied timely.
• Legal proceedings may be instituted against Strive, Semler Scientific, or the combined company, impacting the transaction.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Changes in, or problems arising from, the implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets could negatively affect outcomes.
• General economic and market conditions, interest and exchange rates, monetary policy, laws, and regulations and their enforcement pose risks.
• The integration of the two companies may be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected due to unforeseen factors.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction could cause dilution.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships may occur.
• Changes in Strive's or Semler Scientific's share price before closing could impact the transaction.

Future Outlook

The outlook and expectations for the proposed transaction include anticipated strategic and financial benefits, a positive impact on the combined company's future financial performance, and the successful integration of the combined businesses. The timing of the closing of the proposed transaction is also a key forward-looking aspect.

Management Comments

• Jeff Walton, Chief Risk Officer of Strive, Inc., reposted the communication regarding the proposed business combination with Semler Scientific, Inc.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' indicates that the combined entity may be engaging with or exposed to the volatile digital asset market, a growing but high-risk area for corporate treasury management. This aligns with a broader trend of companies exploring or adopting digital assets, which introduces new layers of financial and operational risk.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a potential risk factor for the proposed transaction.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock in connection with the proposed transaction.
• Customers and employees of both Strive and Semler Scientific may have adverse reactions or experience changes to business or employee relationships as a result of the announcement or completion of the proposed transaction.

Next Steps

• Strive will file a definitive Information Statement/Proxy Statement/Prospectus with the SEC.
• Semler Scientific stockholders will be sent the definitive Information Statement/Proxy Statement/Prospectus to seek their approval of the proposed transaction.
• The proposed transaction will proceed towards closing, subject to conditions being met.
• The combined businesses will undergo integration post-closing.

Key Dates

Recommendation

This filing is a procedural communication related to a proposed business combination, primarily outlining forward-looking statements and associated risks. It does not provide new financial performance data or strategic shifts that would alter an existing investment thesis. Investors should hold pending the definitive Information Statement/Proxy Statement/Prospectus and the successful completion and integration of the merger, while carefully considering the outlined risks, particularly those related to Bitcoin treasury strategies and integration challenges.

Keywords

Strive, Semler Scientific, merger, business combination, SEC filing, Form 425, Bitcoin, digital assets, corporate governance, risk management, financial reporting